Moderna's Booster Candidate Demonstrates Superior Antibody Response Against Omicron

Retrieved on: 2022-06-22 18:54:25

Tags for this article:

Clinical trials

COVID-19 vaccination in the United States

RNA vaccines

Dolly Parton

Moderna

Moderna COVID-19 vaccine

Health

SARS-CoV-2 Omicron variant

Booster dose

COVID-19 vaccine

Coronavirus spike protein

COVID-19 vaccine clinical research

Click the tags to see associated articles and topics

Moderna's Booster Candidate Demonstrates Superior Antibody Response Against Omicron. View article details on HISWAI: https://www.pharmacytimes.com/view/moderna-s-booster-candidate-demonstrates-superior-antibody-response-against-omicron

Excerpt

The booster candidate contained mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern. The 50-µg booster dose met all ...

Article found on: www.pharmacytimes.com

View Original Article